晚发性胆固醇病与罕见但可识别的原因
Advait Aniruddha Gitay1, Prashant Dubey2
1Resident, Department of Neurology, Dr DY Patil Medical College, Dr DY Patil Vidyapeeth (Deemed to be University), Pune, Maharashtra, India, Corresponding Author.
The Journal of the Association of Physicians of India
|June 17, 2024
概括
这一案例突出了急性胆固醇作为小细胞肺癌的潜在症状. 早期检测瘤综合征,如抗CRMP-5/CV2抗体脑炎,对于管理这种运动障碍至关重要.
科学领域:
- 神经学 神经学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 胆是一种运动障碍,原因多种多样,包括自身免疫性,血管性,退行性和副性病因.
- 吸烟是各种癌症的重要危险因素,可以影响神经系统疾病.
研究的目的:
- 报告一种与小细胞肺癌相关的副发性瘤综合征的急性胆固醇病例.
- 强调正子发射断层扫描 (PET) 扫描和特异抗体测试在识别罕见的神经瘤表现的诊断实用性.
主要方法:
- 急性胆固醇的临床表现,有显著的吸烟史.
- 排除常见的血管和代谢病因.
- 全身正子发射断层扫描 (PET) 扫描以识别一次性瘤.
- 活检证实了小细胞肺癌.
- 麻性抗体小组,包括CRMP-5/CV2.
主要成果:
- 一个正电子发射断层扫描 (PET) 扫描显示了右上叶质量.
- 活检证实了小细胞肺癌.
- 对缩蛋白反应介导蛋白5抗原 (CRMP-5/CV2) 的阳性抗体表明了副瘤综合征.
- 患者接受了免疫调节和化疗,反应变化.
结论:
- 急性胆固醇可以是与小细胞肺癌相关的瘤综合征的呈现症状.
- 涉及先进成像和血清学检测的诊断工作对于在不明原因的胆固醇病例中识别潜在恶性瘤至关重要.
- 麻性胆固醇的治疗需要采用多学科的方法,同时应对癌症和神经症状.
更多相关视频
相关概念视频
Parkinson's Disease: Overview
524
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
524
Parkinson's Disease: Treatment
255
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
255
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
569
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
569
Biological Causes of Schizophrenia
54
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
54
Alzheimer's Disease: Overview
462
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
462


